1000002662

Nectar Lifesciences

21.95
+0.13 (0.60%) tick NSE

Last updated on 5 May 2025 03:34 PM

Returns
-1.04%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

489.11

Earning Per Share

0.22

Dividend Yield

-%

P/E Ratio

136.86

P/B Ratio

0.45

Debt to Equity

0.65

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Nectar Lifescience Limited was incorporated on June 27, 1995 with the name 'Surya Medicare Limited'. On March 26, 2004, Company changed their name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'. NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. It is a global pharmaceutical company specializing in Cephalosporins. Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.

Similar Companies